www.fdanews.com/articles/146479-boston-scientific-rsquo-s-lotus-tavi-system-minimizes-leakage-in-early-trial
Boston Scientific’s Lotus TAVI System Minimizes Leakage in Early Trial
May 16, 2012
Boston Scientific’s Lotus transcatheter aortic valve implantation system fared well in an early feasibility study in patients with severe symptomatic aortic stenosis who were too sick to undergo open-heart surgery.
Mass Device
Mass Device